Transforming prevention and treatment of serious bacterial infections

Click here to view online. Add this email to your safelist.

2 July 2025

Serious bacterial infections (SBIs) are major threats recognized globally by organizations like the World Health Organization and other health agencies, with predictions indicating SBI-related deaths could reach 10 million annually by 2050. Together with the broader research community, AstraZeneca is actively pursuing novel treatment and prevention strategies to transform the care of SBIs.

RSS Feed

Legal notice and Terms of Use

Cookie policy

Site map

For more information please visit astrazeneca.com.

If you would like to unsubscribe please click here.